Zur Vor-Weihnachtszeit bei den Klöstern im Klösterreich Straß im Straßertale (ots) - Um die ...
Pain management means more than just selling drugs/Grünenthal's sponsorship of the European Association for Palliative Care (EAPC) underlines the company's commitment to palliative care
Aachen, Germany (ots) - Grünenthal is a pharmaceutical company
based in Aachen, Germany, with subsidiaries in Europe and many other
countries of the world. The main fields of international sales'
activities are anti-infectives and analgesics. Grünenthal's analgesic
portfolio comprises mainly opioids, such as the centrally acting
analgesics tramadol and morphine as well as an innovative
buprenorphine formulation in a matrix patch, the buprenorphine TDS
(http://www.buprenorphine-patch.com). As a manufacturer of key
analgesics essental in the palliative care setting, Grünenthal
supports palliative care structures across Europe and in many other
countries of the world. Consequently, Grünenthal has committed itself
to improving the situation of terminal pain patients by supporting
the emerging hospice movement in Germany and Europe, making donations
to selected initiatives in palliative care and being present at
international palliative care congresses with scientific symposia.
Now, a further piece has been added to the company's commitment in
palliative care by supporting the work of the EAPC with a major EAPC
sponsorship running for two years (http://www.eapcnet.org/home.html).
The European Association for Palliative Care - EAPC - is a non-profit
organisation devoted to improve the knowledge and awareness of health
professionals dedicated to palliative and consequently patient care
in this vital sector of medicine. The organisation is affiliated with
other palliative care associations in various countries, thus
communicating with some 22000 healthcare professionals across Europe.
Bi-annual congresses are organised which promulgate new experiences
and information to palliative medicine professionals.
Grünental's sponsorship will not only cover a considerable amount
of money in each of the two years but also the active participation
of Grünenthal's European subsidiaries in palliative care initiatives
in their own countries. The French Grünenthal subsidiairies have
already started negotiations with the French Chapter of Palliative
Care Association (SFAP) with the aim to become their main sponsor.
ots Originaltextservice: Grünenthal GmbH
Visit our websites: www.pressroom-pain.grunenthal.com,